Spots Global Cancer Trial Database for classic hodgkin's lymphoma
Every month we try and update this database with for classic hodgkin's lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy | NCT04044222 | Classic Hodgkin... | Sintilimab Carboplatin Etoposide Ifosfamide Placebo Carboplatin Etoposide Ifosfamide | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
| A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy | NCT04044222 | Classic Hodgkin... | Sintilimab Carboplatin Etoposide Ifosfamide Placebo Carboplatin Etoposide Ifosfamide | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
| A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy | NCT04044222 | Classic Hodgkin... | Sintilimab Carboplatin Etoposide Ifosfamide Placebo Carboplatin Etoposide Ifosfamide | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
